logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
K

Koji Hasegawa

carol davila university of medicine & pharmacy

70H指数
1.0K论文数
1.9W被引数
收录论文 263
发表时间
logo
Lipid-lowering therapy: Evidence and future perspective降脂疗法：证据与未来展望
errJRSM Cardiovascular Disease
IF1.5
err2026-05-01
err0
PREAI
errKomiyama, Maki; Wada, Hiromichi; Dan, Gheorghe-Andrei; Hasegawa, Koji
err分享
err收藏
Nobiletin Prevents Cardiac Hypertrophy via SIRT5-Mediated Downregulation of p300辛弗林通过SIRT5介导的p300下调预防心肌肥厚
errHypertension
IF8.2
err2026-01-01
err1
PREAI
errSunagawa, Yoichi; Funamoto, Masafumi; Hamabe-Horiike, Toshihide; Hieda, Kehima; Yabuki, Seiichiro; Tomino, Midori; Ikai, Yoshimi; Suzuki, Anna; Ogawahara, Shintaro; Yabuta, Asami; Sasaki, Hana; Ebe, Ayaka; Naito, Shiomi; Takai, Hidemichi; Shimizu, Kana; Shimizu, Satoshi; Kawase, Yuto; Naruta, Ryuya; Katanasaka, Yasufumi; Asakawa, Tomohiro; Kan, Toshiyuki; Mori, Kiyoshi; Murakami, Akira; Ogura, Masahito; Inagaki, Nobuya; Hasegawa, Koji; Morimoto, Tatsuya
err分享
err收藏
Association Between Cardio-Ankle Vascular Index and Heart Failure Outcomes Insights From a Prospective Multicenter Cohort心血管踝指数与心力衰竭结局的关联：一项前瞻性多中心队列研究的启示
errJACC-ADVANCES
IF0
err2025-12-01
err0
errOAAI
errMiyoshi, Toru; Shirai, Kohji; Horinaka, Shigeo; Higaki, Jitsuo; Yamamura, Shigeo; Saiki, Atsuhito; Takahashi, Mao; Okura, Takafumi; Kotani, Kazuhiko; Kubozono, Takuro; Yoshioka, Ryo; Kihara, Hajime; Hasegawa, Koji; Satoh-Asahara, Noriko; Yamaguchi, Osamu; Ito, Hiroshi
err分享
err收藏
CURCUMIN ANALOG INDUCES G2/M ARREST IN HUMAN GLIOBLASTOMA CELLS AT LOWER CONCENTRATIONS THAN CURCUMIN DUE TO ITS HIGHER CELLULAR UPTAKE姜黄素类似物在较低浓度下即可诱导人胶质母细胞瘤细胞发生G2/M期阻滞，这是由于其细胞摄取率更高所致。
errNEURO-ONCOLOGY
IF13.4
err2025-11-01
err0
errOAAI
errIto, Ryo; Hamabe, Toshihide; Sunagawa, Yoichi; Katanasaka, Yasufumi; Arakawa, Yoshiki; Miura, Masatomo; Hasegawa, Koji; Morimoto, Tatsuya
err分享
err收藏
Correction: Cardiac-specific overexpression of PRMT5 exacerbates pressure overload-induced hypertrophy and heart failure更正：PRMT5的心脏特异性过表达加剧了压力超负荷诱导的心肌肥厚和心力衰竭
errJournal of Biomedical Science
IF12.1
err2025-08-29
err0
errOAAI
errYasufumi Katanasaka; Yoichi Sunagawa; Ryoga Sakurai; Mikuto Tojima; Ryuya Naruta; Yuya Hojo; Yuto Kawase; Toshihide Hamabe‑Horiike; Kiyoshi Mori; Koji Hasegawa; Tatsuya Morimoto
err分享
err收藏
CAVI IS A SIGNIFICANT INDICATOR IN PRIMARY PREVENTION OF CARDIOVASCULAR DISEASECAVI是心血管疾病一级预防中的一个重要指标。
errJOURNAL OF HYPERTENSION
IF4.1
err2025-05-01
err0
PREAI
errMiyoshi, Toru; Shirai, Kohji; Horinaka, Shigeo; Higaki, Jitsuo; Yamamura, Shigeo; Saiki, Atsuhito; Hasegawa, Koji; Asahara, Noriko; Doi, Masayuki; Orimo, Hajime
err分享
err收藏
Reduction of hypokalaemia with finerenone: a drug or class-specific effect?
errEUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY
IF6.1
err2025-01-08
err0
PREAI
errRosano, Giuseppe M. C.; Ono, Koh; Imbalzano, Egidio; Hasegawa, Koji
err分享
err收藏
The Cardiomyocyte Hypertrophy Inhibitor RFN-409, Identified by High Throughput Screening Assay, Suppresses Pressure Overload-induced Systolic Dysfunction in Mice by Suppressing p38 Activity通过高通量筛选鉴定出的心肌细胞肥大抑制剂RFN-409，通过抑制p38活性抑制小鼠压力过载诱导的收缩功能障碍。
errCIRCULATION
IF38.6
err2024-11-12
err0
PREAI
errIrokawa, Yudai; Katagiri, Takahiro; Maeda, Risa; Shimizu, Satoshi; Funamoto, Masafumi; Hamabe, Toshihide; Sunagawa, Yoichi; Kawase, Yuto; Naruta, Ryuya; Katanasaka, Yasufumi; Hasegawa, Koji; Morimoto, Tatsuya
err分享
err收藏
Will mineralocorticoid receptor antagonists give impact on HFpEF pharmacotherapy in addition to SGLT2 inhibitors?
errEUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY
IF6.1
err2024-10-29
err0
errOAAI
errKomiyama, Maki; Hasegawa, Koji; Rosano, Giuseppe M. C.
err分享
err收藏
Very short-term effects of single dose of proprotein convertase subtilisin kexin 9 inhibitor therapy before percutaneous coronary intervention
errEUROPEAN HEART JOURNAL
IF35.6
err2024-10-28
err0
PREAI
errKataoka, T.; Uzui, H.; Morishita, T.; Nomura, R.; Tsuji, T.; Shimizu, T.; Mukai, M.; Sato, Y.; Miyoshi, M.; Yamaguchi, J.; Ikeda, H.; Tama, N.; Hasegawa, K.; Ishida, K.; Tada, H.
err分享
err收藏
Impact of diabetes on vascular endothelial growth factor D and cardiovascular mortality in patients with suspected or known coronary artery disease: the ANOX study
errEUROPEAN HEART JOURNAL
IF35.6
err2024-10-28
err0
PREAI
errWada, H.; Suzuki, M.; Matsuda, M.; Ajiro, Y.; Shinozaki, T.; Sakagami, S.; Yonezawa, K.; Shimizu, M.; Funada, J.; Takenaka, T.; Morita, Y.; Nakamura, T.; Abe, M.; Akao, M.; Hasegawa, K.
err分享
err收藏
The impact of sodium-glucose cotransporter 2 inhibitors in post-myocardial infarction management: insights from EMPACT-MI and DAPA-MI trials
errEUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY
IF6.1
err2024-07-10
err0
PREAI
errKato, Eri Toda; Hasegawa, Koji; Ono, Koh
err分享
err收藏
What is the Future Position of Factor XIa Inhibitors for Patients with Atrial Fibrillation?
errEUROPEAN CARDIOLOGY REVIEW
IF3.6
err2024-07-01
err1
errOAAI
errKomiyama, Maki; Iguchi, Moritake; Wada, Hiromichi; Ikeda, Takanori; Dan, Gheorghe-Andrei; Hasegawa, Koji
err分享
err收藏
Should pharmacotherapy targeting lipoprotein(a) be further expanded for patients with diabetes?
errEUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY
IF6.1
err2024-05-02
err0
errOAAI
errSun, Yihong; Hasegawa, Koji; Drexel, Heinz
err分享
err收藏
Five percent weight loss is a significant 1-year predictor and an optimal 5-year cut-off for reducing the number of obesity-related cardiovascular disease risk components: the Japan Obesity and Metabolic Syndrome Study
errFRONTIERS IN ENDOCRINOLOGY
IF4.6
err2024-03-27
err2
errOAAI
errYamakage, Hajime; Jo, Takaaki; Tanaka, Masashi; Kato, Sayaka; Hasegawa, Koji; Masuda, Izuru; Matsuhisa, Munehide; Kotani, Kazuhiko; Noda, Mitsuhiko; Satoh-Asahara, Noriko
err分享
err收藏
KUS121, a VCP modulator, has an ameliorating effect on acute and chronic heart failure without calcium loading via maintenance of intracellular ATP levels
errBIOMEDICINE & PHARMACOTHERAPY
IF7.5
err2024-01-01
err1
errOAAI
errTsuji, Shuhei; Otani, Chiharu; Horie, Takahiro; Watanabe, Shin; Baba, Osamu; Sowa, Naoya; Ide, Yuya; Kashiwa, Asami; Makiyama, Takeru; Imai, Hirohiko; Nakashima, Yasuhiro; Yamasaki, Tomohiro; Xu, Sijia; Matsushita, Kazuki; Suzuki, Keita; Zou, Fuquan; Kume, Eitaro; Hasegawa, Koji; Kimura, Takeshi; Kakizuka, Akira; Ono, Koh
err分享
err收藏
A Complex Interplay: Navigating the Crossroads of Tobacco Use, Cardiovascular Disease, and the COVID-19 Pandemic: A WHF Policy Brief
errGLOBAL HEART
IF3.1
err2024-01-01
err1
errOAAI
errDalmau, Regina; Alanazi, Abdullah M.; Arora, Monika; Banerjee, Amitava; Bianco, Eduardo; Gaalema, Diann E.; Goma, Fastone M.; Hasegawa, Koji; Komiyama, Maki; Rios, Monica Perez; Willett, Jeffrey; Wang, Yunshu
err分享
err收藏
Are NOACs always the best strategy in elderly AF patients?
errEUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY
IF6.1
err2023-11-29
err0
errOAAI
errIguchi, Moritake; Tamargo, Juan; Hasegawa, Koji
err分享
err收藏
What is optimal dual anti-platelet therapy duration after percutaneous coronary intervention?
errEUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY
IF6.1
err2023-11-09
err0
errOAAI
errShiomi, Hiroki; Hasegawa, Koji; Ono, Koh
err分享
err收藏
Association of Cardiothoracic Ratio With Heart Failure Events in Atrial Fibrillation Without Heart Failure: The Fushimi AF Registry
errCIRCULATION
IF38.6
err2023-11-07
err0
PREAI
errIkeda, Syuhei; Hamatani, Yasuhiro; Okamoto, Keita; Nakanishi, Yumiko; Minami, Kimihito; Ishigami, Kenjiro; Doi, Kosuke; Yoshizawa, Takashi; Ide, Yuya; Fujino, Akiko; Ishii, Mitsuru; Iguchi, Moritake; Masunaga, Nobutoyo; Esato, Masahiro; Wada, Hiromichi; Hasegawa, Koji; Abe, Mitsuru; Akao, Masaharu
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
G
Gregory Y.H. Lip
H 指数: 212 · 论文数: 5.6K
K
Kazuwa Nakao
H 指数: 120 · 论文数: 1.2K
Y
Yoshihiro Ogawa
H 指数: 116 · 论文数: 1.4K
T
Takeshi Kimura
H 指数: 103 · 论文数: 1.8K
T
Toru Kita
H 指数: 96 · 论文数: 1.1K
查看更多